Jonathan A. Leff Insider Profile

4 Followers
Jonathan A. Leff, VP, Chief Medical Officer at Halozyme, holds 0.00 shares in Halozyme (Ticker: HALO), holds 45.88K shares in InterMune (Ticker: ITMN). Most recently, Jonathan A. Leff ― shares of Halozyme on ― for an estimated value of ―.
Jonathan A. Leff

Jonathan A. Leff
Halozyme (HALO)
VP, Chief Medical Officer

Ranked #99,404 out of 103,103 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-126.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Jonathan A. Leff does not currently own shares as a corporate insider.
A breakdown of Jonathan A. Leff's holdings

Insider Roles

Halozyme
(HALO)
VP, Chief Medical Officer
Roles that Jonathan A. Leff holds in companies

Most Profitable Insider Trade

Stock:
InterMune
(ITMN)
Rating:Informative Sell
Date:Mar 10, 2014 - Mar 10, 2015
Return:-119.80%
The most profitable trade made by Jonathan A. Leff

Jonathan A. Leff's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Halozyme
VP, Chief Medical Officer
$0.00
ITMN
InterMune
Mar 10, 2014
Informative Sell
$23.75K
List of latest transactions for each holding click on a transaction to see Jonathan A. Leff's performance on stock

Jonathan A. Leff insider profile FAQ

What is the percentage of profitable transactions made by Jonathan A. Leff?
The percentage of profitable transactions made by Jonathan A. Leff is 0%.
    What is the average return per transaction made by Jonathan A. Leff?
    The average return per transaction made by Jonathan A. Leff is -126.70%.
      What stocks does Jonathan A. Leff hold?
      Jonathan A. Leff holds: HALO, ITMN stocks.
        What was Jonathan A. Leff’s latest transaction?
        Jonathan A. Leff latest transaction was an Uninformative Buy of ―.
          What was Jonathan A. Leff's most profitable transaction?
          Jonathan A. Leff’s most profitable transaction was an Informative Sell of ITMN stock on March 10, 2014. The return on the trade was -119.80%.
            What is Jonathan A. Leff's role in Halozyme?
            Jonathan A. Leff's role in Halozyme is VP, Chief Medical Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.